A05生物製劑(生物藥、抗體、蛋白質、疫苗)

GeneFrontier Corporation (GFC) is a Japanese biotech company, which is one of the group companies of KANEKA Corporation. GFC is focusing on biopharmaceutical R&D support business with innovative products and services especially in protein based biologics including antibody. Also, GFC is looking at next era of antibody therapeutics in Biologics. GFC is developing its own new technology for antibody therapeutics and beyond antibodies, like scaffold. Our aim is to explore the potential of protein based Biologics, and contributes the development of innovative therapeutics.

We are providing a unique platform technology named PUREfrex®, which is a fully reconstituted (or rebuilt) cell-free protein expression system. It's easy to customize the system for various applications at the molecular level. It has been widely used not only for the expression of difficult-to-express proteins, including therapeutic biologics, but also as a platform for high-throughput expression or in vitro display, which works synergistically with the AI/ML platform. We are exploring the potential of cell-free technologies in biologics.